Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV) (V116-007, STRIDE-7)
Public ClinicalTrials.gov record NCT05393037. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Adults Living With HIV
Study identification
- NCT ID
- NCT05393037
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Enrollment
- 313 participants
Conditions and interventions
Conditions
Interventions
- V116 Biological
- Placebo Biological
- PCV15 Biological
- PPSV23 Biological
- PCV15 - Part B Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 12, 2022
- Primary completion
- Jul 12, 2023
- Completion
- Jan 24, 2024
- Last update posted
- Feb 4, 2026
2022 – 2024
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pueblo Family Physicians ( Site 0014) | Phoenix | Arizona | 85015 | — |
| Whitman-Walker Institute ( Site 0009) | Washington D.C. | District of Columbia | 20005 | — |
| Midway Immunology and Research Center ( Site 0003) | Ft. Pierce | Florida | 34982 | — |
| Orlando Immunology Center ( Site 0004) | Orlando | Florida | 32803 | — |
| KC CARE Health Center ( Site 0013) | Kansas City | Missouri | 64111 | — |
| North Texas Infectious Diseases Consultants, P.A ( Site 0001) | Dallas | Texas | 75246 | — |
| Texas Center for Infectious Disease Associates ( Site 0011) | Fort Worth | Texas | 76104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05393037, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 4, 2026 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05393037 live on ClinicalTrials.gov.